Cilengitide inhibits metastatic bone colonization in a nude rat model
Cilengitide inhibits phosphorylation of FAK, Src and Akt in glioma... | Download Scientific Diagram
Full article: Cilengitide, an αvβ3-integrin inhibitor, enhances the efficacy of anti-programmed cell death-1 therapy in a murine melanoma model
CILENGITIDE | New Drug Approvals
Integrin Inhibitor Cilengitide for the Treatment of Glioblastoma: A Brief Overview of Current Clinical Results | Anticancer Research
NEWS RELEASE MDxHealth and Merck KGaA extend Agreement for use of MGMT Assay in Brain Cancer Clinical Trials
Integrin Inhibitor Cilengitide for the Treatment of Glioblastoma: A Brief Overview of Current Clinical Results
Cilengitide - Wikipedia
Cilengitide | CAS:188968-51-6 | Integrin inhibitor for αvβ3 and αvβ5 | High Purity | Manufacturer BioCrick
8 Dose–response curves after treatment with cilengitide (CIL),... | Download Scientific Diagram
cilengitide | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY
PDF] Integrin inhibitor cilengitide for the treatment of glioblastoma: a brief overview of current clinical results. | Semantic Scholar
Emerging therapeutic opportunities for integrin inhibitors | Nature Reviews Drug Discovery
Cilengitide trifluoroacetate | 99.8%(HPLC) | In Stock | Integrin inhibitor
Cilengitide induces cellular detachment and apoptosis in endothelial and glioma cells mediated by inhibition of FAK/src/AKT pathway | Journal of Experimental & Clinical Cancer Research | Full Text
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial - The Lancet Oncology
Cilengitide: an RGD pentapeptide ανβ3 and ανβ5 integrin inhibitor in development for glioblastoma and other malignancies | Future Oncology
Frontiers | Cyclic RGD Pentapeptide Cilengitide Enhances Efficacy of Gefitinib on TGF-β1-Induced Epithelial-to-Mesenchymal Transition and Invasion in Human Non-Small Cell Lung Cancer Cells
Frontiers | Cyclic RGD Pentapeptide Cilengitide Enhances Efficacy of Gefitinib on TGF-β1-Induced Epithelial-to-Mesenchymal Transition and Invasion in Human Non-Small Cell Lung Cancer Cells
PDF] Integrin inhibitor cilengitide for the treatment of glioblastoma: a brief overview of current clinical results. | Semantic Scholar
Pharmaceutics | Free Full-Text | Integrin-αvβ3 as a Therapeutic Target in Glioblastoma: Back to the Future?